Literature DB >> 20349215

Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.

Feng Lin1, Shui-er Zheng, Zan Shen, Li-na Tang, Ping Chen, Yuan-jue Sun, Hui Zhao, Yang Yao.   

Abstract

The present study was designed to determine whether the expression of chemokine receptor CXCR4 and vascular endothelial growth factor (VEGF) is correlated with the extent of metastasis and the survival of patients with osteosarcoma. Using tissue microarrays, we analyzed the expression of CXCR4 and VEGF in tumor tissues collected from 56 patients with osteosarcoma. A two-year follow-up was performed to evaluate tumor metastatic behavior and the overall survival of the patients. There was a significant correlation between the expression of CXCR4 and the expression of VEGF in tumor tissues of these patients (P = 0.002). Univariate analysis revealed that expression of these proteins was correlated with clinical stage, but not age, gender, or serum alkaline phosphatase levels. The patients with tumors expressing CXCR4 and VEGF had worse overall survival rates compared with the patients with tumors that did not express CXCR4 (P = 0.03) or VEGF (P = 0.04). These data indicate that CXCR4 and VEGF expression is highly correlated with metastatic progression in patients with osteosarcoma and had predictive value for the metastasis and survival of osteosarcoma patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349215     DOI: 10.1007/s12032-010-9493-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  17 in total

1.  CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.

Authors:  Patrick L Wagner; Elizabeth Hyjek; Madeline F Vazquez; Danish Meherally; Yi Fang Liu; Paul A Chadwick; Tatiana Rengifo; Gabriel L Sica; Jeffrey L Port; Paul C Lee; Subroto Paul; Nasser K Altorki; Anjali Saqi
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09-19       Impact factor: 5.209

2.  Angiogenesis in tumor growth and metastasis.

Authors:  Riichiro Abe
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

3.  Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.

Authors:  Akira Furudoi; Shinji Tanaka; Ken Haruma; Yasuhiko Kitadai; Masaharu Yoshihara; Kazuaki Chayama; Fumio Shimamoto
Journal:  Oncology       Date:  2002       Impact factor: 2.935

Review 4.  The significance of cancer cell expression of the chemokine receptor CXCR4.

Authors:  Fran Balkwill
Journal:  Semin Cancer Biol       Date:  2004-06       Impact factor: 15.707

Review 5.  Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.

Authors:  George W Sledge
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

6.  Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.

Authors:  John P Mongan; Camilo E Fadul; Bernard F Cole; Bassem I Zaki; Arief A Suriawinata; Gregory H Ripple; Tor D Tosteson; J Marc Pipas
Journal:  Clin Colorectal Cancer       Date:  2009-03       Impact factor: 4.481

7.  CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.

Authors:  Zhongxing Liang; Joann Brooks; Margaret Willard; Ke Liang; Younghyoun Yoon; Seunghee Kang; Hyunsuk Shim
Journal:  Biochem Biophys Res Commun       Date:  2007-06-04       Impact factor: 3.575

8.  CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis.

Authors:  Yoshinao Oda; Hidetaka Yamamoto; Sadafumi Tamiya; Shuichi Matsuda; Kazuhiro Tanaka; Ryohei Yokoyama; Yukihide Iwamoto; Masazumi Tsuneyoshi
Journal:  Mod Pathol       Date:  2006-05       Impact factor: 7.842

9.  CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma.

Authors:  Y-C Yang; Z-Y Lee; C-C Wu; T-C Chen; C-L Chang; C-P Chen
Journal:  Int J Gynecol Cancer       Date:  2007 May-Jun       Impact factor: 3.437

10.  High VEGF with rapid growth and early metastasis in a mouse osteosarcoma model.

Authors:  Shang-You Yang; Haiying Yu; Jeffrey E Krygier; Paul H Wooley; Michael P Mott
Journal:  Sarcoma       Date:  2007
View more
  29 in total

1.  Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.

Authors:  Gang Han; Yan Wang; Wenzhi Bi; Jinpeng Jia; Wei Wang; Meng Xu
Journal:  Clin Exp Med       Date:  2015-08-29       Impact factor: 3.984

Review 2.  Progress in the chemotherapeutic treatment of osteosarcoma.

Authors:  Ya Zhang; Jingqing Yang; Na Zhao; Cao Wang; Santosh Kamar; Yonghong Zhou; Zewei He; Jifei Yang; Bin Sun; Xiaoqian Shi; Lei Han; Zuozhang Yang
Journal:  Oncol Lett       Date:  2018-09-12       Impact factor: 2.967

3.  Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.

Authors:  Steven G DuBois; Diana Stempak; Bing Wu; Reza Bayat Mokhtari; Rakesh Nayar; Katherine A Janeway; Robert Goldsby; Holcombe E Grier; Sylvain Baruchel
Journal:  Pediatr Blood Cancer       Date:  2011-02-11       Impact factor: 3.167

4.  Comment on Zhuang YF et al.: impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.

Authors:  Jinlong Ma; Ling Fang; Feng Zhang
Journal:  Tumour Biol       Date:  2014-08-12

5.  Altered CXCL12 expression reveals a dual role of CXCR4 in osteosarcoma primary tumor growth and metastasis.

Authors:  Olga Neklyudova; Matthias J E Arlt; Patrick Brennecke; Marcus Thelen; Ana Gvozdenovic; Aleksandar Kuzmanov; Bernhard Robl; Sander M Botter; Walter Born; Bruno Fuchs
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-14       Impact factor: 4.553

Review 6.  A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.

Authors:  Ding Chen; Ye-Jia Zhang; Ke-wei Zhu; Wan-Chun Wang
Journal:  Tumour Biol       Date:  2013-04-16

7.  Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma.

Authors:  Melanie A Krook; Lauren A Nicholls; Christopher A Scannell; Rashmi Chugh; Dafydd G Thomas; Elizabeth R Lawlor
Journal:  Mol Cancer Res       Date:  2014-03-20       Impact factor: 5.852

8.  High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases.

Authors:  Chin-Sheng Hung; Hou-Yu Su; Hung-Hwa Liang; Chieh-Wen Lai; Yo-Cheng Chang; Yuan-Soon Ho; Chih-Hsiung Wu; Jau-De Ho; Po-Li Wei; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2013-10-08

9.  Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.

Authors:  Yanfeng Zhuang; Meiyang Wei
Journal:  Tumour Biol       Date:  2014-02-11

10.  Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.

Authors:  Yong-Jiang Li; Yi-Ling Dai; Wen-Biao Zhang; Shuang-Jiang Li; Chong-Qi Tu
Journal:  Clin Exp Med       Date:  2015-12-17       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.